{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:02:45Z","timestamp":1648893765839},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>For patients taking warfarin and undergoing pacemaker or implantable cardioverter-defibrillator surgery, clinical evidence and guidelines support continuation of warfarin therapy, as opposed to interruption of warfarin therapy with heparin bridging. Interruption of warfarin without post-operative bridging therapy may be a feasible alternative but data is sparse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a single-arm observational study including adults who had interruption of warfarin therapy without post-operative bridging therapy for cardiac implantable electronic device (CIED) surgery performed between 2010 and 2019 in a tertiary referral hospital. The primary outcome was a composite of all-cause mortality, arterial or venous thromboembolic events. The secondary outcomes were clinically significant device-pocket hematoma and other procedural complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 411 patients analysed including 257 patients (62.5%) who had mechanical heart valves, the primary outcome developed in 5 (1.2%) patients within 30\u2009days after surgery, including death in 3 (0.7%) patients, transient ischemic attack in 1 (0.2%) patient and non-CNS embolism in 1 (0.2%) patient. Clinically significant hematomas occurred in 24 (5.8%) patients, including 15 (3.7%) requiring additional interruption of anti-coagulation and 6 (1.5%) requiring clot evacuation. Other procedural complications and bleeding events were rare (&lt;\u20091%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Warfarin interruption without post-operative bridging therapy for CIED surgery was associated with low thromboembolic risks and acceptable bleeding risk. Randomized controlled trials are required to formulate an optimal approach to anti-coagulation management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-021-00279-6","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T10:03:07Z","timestamp":1619690587000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks"],"prefix":"10.1186","volume":"19","author":[{"given":"Andrew Kei-Yan","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline Yeung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Wai-Ying","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"issue":"8","key":"279_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","volume":"34","author":"HG Mond","year":"2011","unstructured":"Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a world Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34(8):1013\u201327. https:\/\/doi.org\/10.1111\/j.1540-8159.2011.03150.x.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"279_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225\u201337. https:\/\/doi.org\/10.1056\/NEJMoa043399.","journal-title":"N Engl J Med"},{"issue":"9","key":"279_CR3","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jacc.2003.09.067","volume":"43","author":"AJ Greenspon","year":"2004","unstructured":"Greenspon AJ, Hart RG, Dawson D, Hellkamp AS, Silver M, Flaker GC, et al. Predictors of stroke in patients paced for sick sinus syndrome. J Am Coll Cardiol. 2004;43(9):1617\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.067.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"279_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/eurheartj\/ehr022","volume":"32","author":"JC Nielsen","year":"2011","unstructured":"Nielsen JC, Thomsen PE, Hojberg S, et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J. 2011;32(6):686\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehr022.","journal-title":"Eur Heart J"},{"issue":"25","key":"279_CR5","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","volume":"363","author":"AS Tang","year":"2010","unstructured":"Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363(25):2385\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1009540.","journal-title":"N Engl J Med"},{"issue":"1","key":"279_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1540-8159.2011.03257.x","volume":"35","author":"DZ Uslan","year":"2012","unstructured":"Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE registry. Pacing Clin Electrophysiol. 2012;35(1):81\u20137. https:\/\/doi.org\/10.1111\/j.1540-8159.2011.03257.x.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"11","key":"279_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jacc.2016.01.009","volume":"67","author":"V Essebag","year":"2016","unstructured":"Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study. J Am Coll Cardiol. 2016;67(11):1300\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.009.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"279_CR8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","volume":"171","author":"MR Sohail","year":"2011","unstructured":"Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171(20):1821\u20138. https:\/\/doi.org\/10.1001\/archinternmed.2011.441.","journal-title":"Arch Intern Med"},{"issue":"22","key":"279_CR9","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1302946.","journal-title":"N Engl J Med"},{"issue":"4","key":"279_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/pace.12557","volume":"38","author":"RT Sant'anna","year":"2015","unstructured":"Sant'anna RT, Leiria TL, Nascimento T, et al. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study. Pacing Clin Electrophysiol. 2015;38(4):417\u201323. https:\/\/doi.org\/10.1111\/pace.12557.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"7","key":"279_CR11","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/europace\/euu369","volume":"17","author":"X Yang","year":"2015","unstructured":"Yang X, Wang Z, Zhang Y, Yin X, Hou Y. The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis. Europace. 2015;17(7):1076\u201384. https:\/\/doi.org\/10.1093\/europace\/euu369.","journal-title":"Europace"},{"issue":"9","key":"279_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1501035","volume":"373","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373(9):823\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1501035.","journal-title":"N Engl J Med"},{"issue":"4","key":"279_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","volume":"378","author":"JC Kwong","year":"2018","unstructured":"Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1702090.","journal-title":"N Engl J Med"},{"issue":"38","key":"279_CR14","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210.","journal-title":"Eur Heart J"},{"issue":"8","key":"279_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/europace\/euv190","volume":"17","author":"C Sticherling","year":"2015","unstructured":"Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, et al. Antithrombotic management in patients undergoing electrophysiological procedures: a European heart rhythm association (EHRA) position document endorsed by the ESC working group thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2015;17(8):1197\u2013214. https:\/\/doi.org\/10.1093\/europace\/euv190.","journal-title":"Europace"},{"issue":"7","key":"279_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","volume":"69","author":"JU Doherty","year":"2017","unstructured":"Doherty JU, Gluckman TJ, Hucker WJ, Januzzi JL Jr, Ortel TL, Saxonhouse SJ, et al. 2017 ACC expert consensus decision pathway for Periprocedural Management of Anticoagulation in patients with Nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol. 2017;69(7):871\u201398. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.024.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"279_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/europace\/euw127","volume":"18","author":"JC Deharo","year":"2016","unstructured":"Deharo JC, Sciaraffia E, Leclercq C, Amara W, Doering M, Bongiorni MG, et al. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European snapshot survey on procedural routines for electronic device implantation (ESS-PREDI). Europace. 2016;18(5):778\u201384. https:\/\/doi.org\/10.1093\/europace\/euw127.","journal-title":"Europace"},{"issue":"13","key":"279_CR18","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","volume":"126","author":"D Siegal","year":"2012","unstructured":"Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation. 2012;126(13):1630\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.105221.","journal-title":"Circulation"},{"issue":"3","key":"279_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1540-8159.2008.02247.x","volume":"32","author":"M Robinson","year":"2009","unstructured":"Robinson M, Healey JS, Eikelboom J, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009;32(3):378\u201382. https:\/\/doi.org\/10.1111\/j.1540-8159.2008.02247.x.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"279_CR20","doi-asserted-by":"publisher","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e326S\u2013e50S. https:\/\/doi.org\/10.1378\/chest.11-2298.","journal-title":"Chest"},{"issue":"1","key":"279_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","volume":"122","author":"RH White","year":"1995","unstructured":"White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med. 1995;122(1):40\u20132. https:\/\/doi.org\/10.7326\/0003-4819-122-1-199501010-00006.","journal-title":"Ann Intern Med"},{"issue":"6","key":"279_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.hrthm.2010.02.018","volume":"7","author":"I Ahmed","year":"2010","unstructured":"Ahmed I, Gertner E, Nelson WB, House CM, Dahiya R, Anderson CP, et al. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm. 2010;7(6):745\u20139. https:\/\/doi.org\/10.1016\/j.hrthm.2010.02.018.","journal-title":"Heart Rhythm"},{"issue":"9","key":"279_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/clc.22726","volume":"40","author":"E Black-Maier","year":"2017","unstructured":"Black-Maier E, Kim S, Steinberg BA, Fonarow GC, Freeman JV, Kowey PR, et al. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017;40(9):746\u201351. https:\/\/doi.org\/10.1002\/clc.22726.","journal-title":"Clin Cardiol"},{"issue":"4","key":"279_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.thromres.2014.07.028","volume":"134","author":"S Schulman","year":"2014","unstructured":"Schulman S, Healey JS, Douketis JD, Delaney J, Morillo CA. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial. Thromb Res. 2014;134(4):814\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2014.07.028.","journal-title":"Thromb Res"},{"issue":"3","key":"279_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/CIRCEP.111.969105","volume":"5","author":"ML Bernard","year":"2012","unstructured":"Bernard ML, Shotwell M, Nietert PJ, Gold MR. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol. 2012;5(3):468\u201374. https:\/\/doi.org\/10.1161\/CIRCEP.111.969105.","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-021-00279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-021-00279-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-021-00279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T10:16:52Z","timestamp":1619691412000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-021-00279-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/s12959-021-00279-6","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Hong Kong \/ Hospital Authority, and a waiver of informed consent was granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nil.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}